Table 1.

Statistics of the participants in this study.

	All [N(%)]	Male [N(%)]	Female [N(%)]	Age (y) [median (range)]
Number of participants	460 (100.0)	268 (58.3)	192 (41.7)	55 (22–92)
CRC	198 (100.0)	120 (60.6)	78 (39.4)	63 (22–92)
Stage 0	5 (100.0)	4 (80.0)	1 (20.0)	67 (38–72)
Stage I	32 (100.0)	15 (46.9)	17 (53.1)	64 (30–86)
Stage II	58 (100.0)	41 (70.7)	17 (29.3)	63 (31–84)
Stage III	59 (100.0)	29 (49.2)	30 (50.8)	63 (38–84)
Stage IV	21 (100.0)	16 (76.2)	5 (23.8)	56 (41–78)
Unknown stage	23 (100.0)	15 (65.2)	8 (34.8)	68 (22–92)
AA	20 (100.0)	14 (70.0)	6 (30.0)	63 (46–76)
SP	101 (100.0)	62 (61.4)	39 (38.6)	55 (24–84)
NED	141 (100.0)	72 (51.1)	69 (48.9)	48 (22–83)